These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30860872)

  • 1. The emerging role of xanthine oxidase inhibition for suppression of breast cancer cell migration and metastasis associated with hypercholesterolemia.
    Oh SH; Choi SY; Choi HJ; Ryu HM; Kim YJ; Jung HY; Cho JH; Kim CD; Park SH; Kwon TH; Kim YL
    FASEB J; 2019 Jun; 33(6):7301-7314. PubMed ID: 30860872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen.
    Ogura J; Kuwayama K; Sasaki S; Kaneko C; Koizumi T; Yabe K; Tsujimoto T; Takeno R; Takaya A; Kobayashi M; Yamaguchi H; Iseki K
    Biochem Pharmacol; 2015 Sep; 97(1):89-98. PubMed ID: 26119820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine Oxidase Inhibitor, Febuxostat Ameliorates the High Salt Intake-Induced Cardiac Hypertrophy and Fibrosis in Dahl Salt-Sensitive Rats.
    Namai-Takahashi A; Sakuyama A; Nakamura T; Miura T; Takahashi J; Kurosawa R; Kohzuki M; Ito O
    Am J Hypertens; 2019 Jan; 32(1):26-33. PubMed ID: 30277494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats.
    Xu D; Murakoshi N; Tajiri K; Duo F; Okabe Y; Murakata Y; Yuan Z; Li S; Aonuma K; Song Z; Shimoda Y; Mori H; Sato A; Nogami A; Aonuma K; Ieda M
    Clin Sci (Lond); 2021 Oct; 135(20):2409-2422. PubMed ID: 34386810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
    Nambu H; Takada S; Maekawa S; Matsumoto J; Kakutani N; Furihata T; Shirakawa R; Katayama T; Nakajima T; Yamanashi K; Obata Y; Nakano I; Tsuda M; Saito A; Fukushima A; Yokota T; Nio-Kobayashi J; Yasui H; Higashikawa K; Kuge Y; Anzai T; Sabe H; Kinugawa S
    Cardiovasc Res; 2021 Feb; 117(3):805-819. PubMed ID: 32402072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice.
    Nishikawa T; Nagata N; Shimakami T; Shirakura T; Matsui C; Ni Y; Zhuge F; Xu L; Chen G; Nagashimada M; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S; Ota T
    Sci Rep; 2020 Jan; 10(1):815. PubMed ID: 31965018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lung.
    Kataoka H; Yang K; Rock KL
    Eur J Pharmacol; 2015 Jan; 746():174-9. PubMed ID: 25449036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production.
    Malik UZ; Hundley NJ; Romero G; Radi R; Freeman BA; Tarpey MM; Kelley EE
    Free Radic Biol Med; 2011 Jul; 51(1):179-84. PubMed ID: 21554948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthine oxidase-generated hydrogen peroxide is a consequence, not a mediator of cell death.
    Czupryna J; Tsourkas A
    FEBS J; 2012 Mar; 279(5):844-55. PubMed ID: 22230240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK.
    Nomura J; Busso N; Ives A; Tsujimoto S; Tamura M; So A; Yamanaka Y
    PLoS One; 2013; 8(9):e75527. PubMed ID: 24086554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease.
    Schmidt HM; Wood KC; Lewis SE; Hahn SA; Williams XM; McMahon B; Baust JJ; Yuan S; Bachman TN; Wang Y; Oh JY; Ghosh S; Ofori-Acquah SF; Lebensburger JD; Patel RP; Du J; Vitturi DA; Kelley EE; Straub AC
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):769-782. PubMed ID: 33267657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Crucial Role of Xanthine Oxidase in CKD Progression Associated with Hypercholesterolemia.
    Kim YJ; Oh SH; Ahn JS; Yook JM; Kim CD; Park SH; Cho JH; Kim YL
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.
    Nokin MJ; Bellier J; Durieux F; Peulen O; Rademaker G; Gabriel M; Monseur C; Charloteaux B; Verbeke L; van Laere S; Roncarati P; Herfs M; Lambert C; Scheijen J; Schalkwijk C; Colige A; Caers J; Delvenne P; Turtoi A; Castronovo V; Bellahcène A
    Breast Cancer Res; 2019 Jan; 21(1):11. PubMed ID: 30674353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
    Zhao L; Roche BM; Wessale JL; Kijtawornrat A; Lolly JL; Shemanski D; Hamlin RL
    Life Sci; 2008 Feb; 82(9-10):495-502. PubMed ID: 18215719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.
    Kohagura K; Tana T; Higa A; Yamazato M; Ishida A; Nagahama K; Sakima A; Iseki K; Ohya Y
    Hypertens Res; 2016 Aug; 39(8):593-7. PubMed ID: 27075830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B; Ni J; Vatish M; Singer DR
    Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
    Šmelcerović A; Tomović K; Šmelcerović Ž; Petronijević Ž; Kocić G; Tomašič T; Jakopin Ž; Anderluh M
    Eur J Med Chem; 2017 Jul; 135():491-516. PubMed ID: 28478180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase inhibition attenuates skeletal muscle signaling following acute exercise but does not impair mitochondrial adaptations to endurance training.
    Wadley GD; Nicolas MA; Hiam DS; McConell GK
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E853-62. PubMed ID: 23462817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
    Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
    Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.